Search results
Novavax to sell 7% stake to South Korea's SK Bioscience
Reuters via AOL· 10 months ago(Reuters) -SK Bioscience is taking a roughly 7% stake in Novavax in lieu of some payment owed to the South Korean biotech company, giving the cash-strapped COVID-19 vaccine maker some breathing ...
Novavax (NVAX) Gets Nod for COVID-19 Booster Jab in South Korea
Zacks via Yahoo Finance· 1 year agoNovavax NVAX announced that its partner SK bioscience received expanded manufacturing and marketing...
Novavax (NVAX) Q2 Earnings Beat, Stock Down 4% on '23 Sales Cut
Zacks via Yahoo Finance· 10 months agoNovavax (NVAX) reports better-than-expected Q2 earnings results, as earnings and revenues beat...
This Leading South Korean Chipmaker Eyes US For Advanced Chip Packaging Plant: Report
Benzinga via Yahoo Finance· 2 years agoSouth Korea's SK Hynix Inc (OTC: HXSCL) targeted a U.S. site for its advanced chip packaging plant...
Why Novavax Stock Is Skyrocketing This Week
Motley Fool· 2 years agoShares of Novavax (NASDAQ: NVAX) were skyrocketing 31.6% this week as of 3:18 p.m. ET on Thursday, according to data provided by S&P Global Market...
Why Novavax Stock Is Jumping Today
Motley Fool· 2 years agoShares of Novavax (NASDAQ: NVAX) were jumping 6.3% as of 10:44 a.m. ET on Monday. The nice gain came after the company announced that Swiss regulators...
Q4 2023 Arcus Biosciences Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 months agoParticipants Pia Eaves; Vice President, Investor Relations; Arcus Biosciences Inc Terry Rosen; Chief Executive Officer; Arcus Biosciences Inc Jennifer Jarrett; Chief Operating Officer; Arcus ...
Novavax's (NVAX) COVID-19 Booster Recommended in Switzerland
Zacks via Yahoo Finance· 2 years agoThe Federal Office of Public Health in Switzerland recommends Novavax's (NVAX) COVID-19 vaccine,...
UPDATE 2-Novavax posts quarterly profit on COVID vaccine sales
Reuters via Yahoo Finance· 10 months agoNovavax reported a second-quarter profit on Tuesday, helped by strong revenue from its COVID-19 vaccines, but still trimmed its full-year forecast for sales of the shot. The biotech company ...
GSK's Key Drugs to Drive Sales in a Sluggish Second Half
Zacks via Yahoo Finance· 2 years agoGSK's specialty products like Dovato, Nucala, Trelegy Ellipta, Shingrix are driving sales, making up...
